Literature DB >> 33842836

Strategies for advanced personalized tuberculosis diagnosis: Current technologies and clinical approaches.

Xuerong Chen1, Tony Y Hu2.   

Abstract

Diagnosis of tuberculosis can be difficult as advances in molecular diagnosis approaches (especially nanoparticles combined with high-throughput mass spectrometry for detecting mycobacteria peptide) and personalized medicine result in many changes to the diagnostic framework. This review will address issues concerning novel technologies from bench to bed and new strategies for personalized tuberculosis diagnosis.
© The Author(s) 2020. Published by Oxford University Press on behalf West China School of Medicine & West China Hospital of Sichuan University.

Entities:  

Keywords:  molecular diagnosis; personalized medicine; tuberculosis

Year:  2021        PMID: 33842836      PMCID: PMC8023014          DOI: 10.1093/pcmedi/pbaa041

Source DB:  PubMed          Journal:  Precis Clin Med        ISSN: 2516-1571


  48 in total

1.  Multi-center evaluation of GenoType MTBDRsl line probe assay for rapid detection of pre-XDR and XDR Mycobacterium tuberculosis in China.

Authors:  Yazhou Gao; Zhengdong Zhang; Jianping Deng; Mikael Mansjö; Zhu Ning; Yang Li; Xuliang Li; Yi Hu; Sven Hoffner; Biao Xu
Journal:  J Infect       Date:  2018-06-30       Impact factor: 6.072

2.  Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring.

Authors:  Chang Liu; Zhen Zhao; Jia Fan; Christopher J Lyon; Hung-Jen Wu; Dobrin Nedelkov; Adrian M Zelazny; Kenneth N Olivier; Lisa H Cazares; Steven M Holland; Edward A Graviss; Ye Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-27       Impact factor: 11.205

3.  Direct Detection of Rifampin and Isoniazid Resistance in Sputum Samples from Tuberculosis Patients by High-Resolution Melt Curve Analysis.

Authors:  Divya Anthwal; Rakesh Kumar Gupta; Manpreet Bhalla; Shinjini Bhatnagar; Jaya Sivaswami Tyagi; Sagarika Haldar
Journal:  J Clin Microbiol       Date:  2017-03-22       Impact factor: 5.948

Review 4.  Tuberculosis.

Authors:  Jennifer Furin; Helen Cox; Madhukar Pai
Journal:  Lancet       Date:  2019-03-20       Impact factor: 79.321

5.  Feasibility and Operational Performance of Tuberculosis Detection by Loop-Mediated Isothermal Amplification Platform in Decentralized Settings: Results from a Multicenter Study.

Authors:  Christen M Gray; Achilles Katamba; Pratibha Narang; Jorge Giraldo; Carlos Zamudio; Moses Joloba; Rahul Narang; C N Paramasivan; Doris Hillemann; Pamela Nabeta; Danielle Amisano; David Alland; Frank Cobelens; Catharina C Boehme
Journal:  J Clin Microbiol       Date:  2016-05-18       Impact factor: 5.948

6.  High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening.

Authors:  Tolu Oni; Rachael Burke; Relebohile Tsekela; Nonzwakazi Bangani; Ronnett Seldon; Hannah P Gideon; Kathryn Wood; Katalin A Wilkinson; Tom H M Ottenhoff; Robert J Wilkinson
Journal:  Thorax       Date:  2011-05-31       Impact factor: 9.139

7.  Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.

Authors:  Stephen D Lawn; Andrew D Kerkhoff; Monica Vogt; Robin Wood
Journal:  Lancet Infect Dis       Date:  2011-10-17       Impact factor: 25.071

8.  Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India.

Authors:  Raj N Yadav; Binit K Singh; Surendra K Sharma; Rohini Sharma; Manish Soneja; Vishnubhatla Sreenivas; Vithal P Myneedu; Mahmud Hanif; Ashok Kumar; Kuldeep S Sachdeva; Chinnambedu N Paramasivan; Balasangameshwra Vollepore; Rahul Thakur; Neeraj Raizada; Suresh K Arora; Sanjeev Sinha
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

9.  A Large Cohort Study on the Clinical Value of Simultaneous Amplification and Testing for the Diagnosis of Pulmonary Tuberculosis.

Authors:  Liping Yan; Shenjie Tang; Yan Yang; Xiang Shi; Yanping Ge; Wenwen Sun; Yidian Liu; Xiaohui Hao; Xuwei Gui; Hongyun Yin; Ya He; Qing Zhang
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.889

10.  Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis.

Authors:  Gian Luca Di Tanna; Ali Raza Khaki; Grant Theron; Kerrigan McCarthy; Helen Cox; Lucy Mupfumi; Anete Trajman; Lynn Sodai Zijenah; Peter Mason; Tsitsi Bandason; Betina Durovni; Wilbert Bara; Michael Hoelscher; Petra Clowes; Chacha Mangu; Duncan Chanda; Alexander Pym; Peter Mwaba; Frank Cobelens; Mark P Nicol; Keertan Dheda; Gavin Churchyard; Katherine Fielding; John Z Metcalfe
Journal:  Lancet Glob Health       Date:  2019-02       Impact factor: 26.763

View more
  1 in total

1.  Silicon Nanodisk Huygens Metasurfaces for Portable and Low-Cost Refractive Index and Biomarker Sensing.

Authors:  Isaac O Oguntoye; Brittany K Simone; Siddharth Padmanabha; George Z Hartfield; Pouya Amrollahi; Tony Y Hu; Adam J Ollanik; Matthew D Escarra
Journal:  ACS Appl Nano Mater       Date:  2022-03-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.